You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Safe Track Protection and Advance Warning System

    SBC: WAVETRONIX LLC            Topic: 082FH1

    To improve safety and efficiency on high-speed signalized intersections a dilemma zone protection system has been designed to automatically configure site-specific protection boundaries on both main-street approaches by continously tracking vehicles within up to 1000 feet of each stop line. The system will further customize and refine protection by continously estimating the probability of a seve ...

    SBIR Phase I 2009 Department of Transportation
  2. A Higher Performance Traffic Detector Built on SmartSensor HD and Multi-Beam Radar Technology

    SBC: WAVETRONIX LLC            Topic: 091FH3

    Wavetronix currently sells the SmartSensor HD radar detection which is the highest performance above ground detector currently available. However, the count, speed and classification accuracy can be significantlly improved by employing multi-beam radar technology which we have recently developed. Multi-beam radar technology allows multiple radars to be used cost effectively inside a single senso ...

    SBIR Phase I 2009 Department of Transportation
  3. Multifunctional Carriers for Systemic siRNA Delivery

    SBC: SURFAGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objectives of this research project are to design and develop safe and efficient multifunctional delivery systems for systemic and target-specific delivery of small interfering RNA (siRNA) to treat human diseases with RNA interference (RNAi). RNAi is a natural mechanism for gene silencing and has a great potential to treat human disease by turning off speci ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Aptamer-based Glycomics Tools

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. Therefore, developing novel tools that allow for the rapid detection of glycosylation patterns is of tremendous importance to the field of glycomics. In this application, we propose to develop a nove ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Characterization of Respiratory Pathogens in Transplant Patients

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): Immunocompromised patients including those who have undergone hematopoietic stem cell (HSCT) and solid organ (SOT) transplants are at markedly increased risk for severe disease caused by respiratory pathogens. These patients have greater susceptibility to a broader range of organisms and frequently present with more advanced disease. In addition, they often hav ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Miniature EEG Telemetry Device for Translational Epilepsy Research

    SBC: EPITEL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Long-term continuous recording of electrical events from animal models of neurological disease is a critical component of translational research aimed at developing new therapies for debilitating disorders, such as epilepsy. Recordings of the electroencephalogram (EEG) can be obtained for weeks or months at a time from adult rats with either tethered (i.e., w ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. Sulfated Polysaccharide Derivatives for the Treatment of Rosacea

    SBC: GLYCOMIRA, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Rosacea is a common disfiguring skin disease affecting 3% of the population over 30 years of age, or 14 million Americans. In men and women of Celtic origin, Rosacea causes central erythema of the face, with highly visible dilated blood vessels and pustules. Dry, itchy eyes are also common. In men, Rosacea can thicken the skin of the nose to create the classic ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. Sulfated Polysaccharide Derivatives for Treatment of Macular Degeneration

    SBC: GLYCOMIRA, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is a leading cause of blindness in the U.S., affecting 8 million Americans over fifty years of age. Its cause is rooted in the highly oxidizing environment of the retina, which is simultaneously exposed to UV light and high oxygen tensions. Over a lifetime, oxidant events in the retina lead to accumulation of drusen, a com ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Protein-modified Hydrogels for Expansion of Human Embryonic Stem Cells

    SBC: GLYCOSAN BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The realization of the remarkable potential of human embryonic stem cells or induced pluripotent stem cells to treat human disease cannot occur unless new animal-free methods for the expansion of undifferentiated stem cells are developed. An optimal extracellular matrix (ECM) substitute for the expansion of human embryonic stem cells (hESCs) in three dimensions ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Technology for isolation of Integrase Inhibitors for Therapeutics against Human I

    SBC: INTEGRATECH PROTEOMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Currently there are 40 million people estimated to be infected with HIV/AIDS worldwide; 22 million people have died since its discovery in 1980's. Drugs inhibiting the reverse transcriptase (RT), protease, and integrase - three essential enzymes for the replication and propagation of HIV in the host - are available. However, viral resistance and drug side effec ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government